- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Brake on Nerve Repair Identified
18 January 2001 7:00 pm
Unlike skin cells, neurons in the brain and spinal cord don't grow back after they've been injured. This intransigence seems to crop up as soon as developing neurons grow their insulating sheath made of myelin. Last year, scientists found the gene for a protein in myelin that shut down nerve growth. But they had no idea how this protein signal, called Nogo, gets picked up.
To find out, a team led by Stephen Strittmatter of Yale University sampled genes expressed in mouse brain to look for ones that would allow nonneuronal cells to bind Nogo (which they normally wouldn't do). They found their needle in a haystack: a gene they named NgR. Another experiment bolstered the idea that NgR is a Nogo receptor: When young neurons were manipulated to produce the NgR protein, they stopped growing in the presence of Nogo, the team reports in the 18 January issue of Nature.
The finding gives researchers "a very strong handle" on how Nogo stops nerve growth, says Marie Filbin of Hunter College of the City University of New York. Buoyed by this understanding, Strittmatter hopes that injured neurons could be encouraged to regrow, perhaps with a small molecule or peptide to disrupt the partnering of Nogo with its receptor. Such a treatment may eventually help people with spinal cord injuries. But just blocking only NgR may not be enough, cautions Filbin, who thinks that other signals besides Nogo may block regrowth.